DHFB
AGN

Dixon Hubard Feinour & Brown’s Allergan plc AGN Stock Holding History

Dixon Hubard Feinour & Brown’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-12,690
Closed -$2.13M – 187
2019
Q2 		$2.13M Buy
12,690
+80
+0.6% +$11.1K 0.6% 46
2019
Q1 		$1.85M Sell
12,610
-100
-0.8% -$14.5K 0.56% 50
2018
Q4 		$1.7M Buy
12,710
+125
+1% +$20.5K 0.63% 46
2018
Q3 		$2.4M Buy
12,585
+1,525
+14% +$280K 0.66% 44
2018
Q2 		$1.84M Buy
11,060
+60
+0.5% +$9.63K 0.54% 53
2018
Q1 		$1.85M Sell
11,000
-350
-3% -$58.7K 0.52% 56
2017
Q4 		$1.86M Sell
11,350
-1,520
-12% -$273K 0.5% 56
2017
Q3 		$2.64M Sell
12,870
-440
-3% -$102K 0.76% 42
2017
Q2 		$3.24M Sell
13,310
-355
-3% -$83.4K 0.93% 35
2017
Q1 		$3.27M Sell
13,665
-159
-1% -$37K 0.97% 31
2016
Q4 		$2.9M Sell
13,824
-525
-4% -$109K 0.92% 36
2016
Q3 		$3.31M Sell
14,349
-715
-5% -$175K 1.03% 32
2016
Q2 		$3.48M Hold
15,064
– – 1.11% 32
2016
Q1 		$3.26M Sell
15,064
-1,015
-6% -$291K 1.07% 33
2015
Q4 		$5.03M Buy
16,079
+70
+0.4% +$20.8K 1.6% 22
2015
Q3 		$4.35M Buy
16,009
+260
+2% +$79.9K 1.6% 23
2015
Q2 		$4.78M Sell
15,749
-1,431
-8% -$427K 1.47% 26
2015
Q1 		$5.11M Sell
17,180
-1,159
-6% -$330K 1.51% 18
2014
Q4 		$4.72M Buy
18,339
+235
+1% +$58.7K 1.47% 24
2014
Q3 		$4.37M Buy
18,104
+159
+0.9% +$35.6K 1.43% 25
2014
Q2 		$4M Sell
17,945
-650
-3% -$135K 1.31% 29
2014
Q1 		$3.83M Buy
18,595
+450
+2% +$89.1K 1.33% 28
2013
Q4 		$3.05M Sell
18,145
-150
-0.8% -$23.4K 1.13% 35
2013
Q3 		$2.63M Buy
18,295
+275
+2% +$36.6K 1.12% 36
2013
Q2 		$2.27M Buy
+18,020
New +$2.04M 1.01% 39

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Dixon Hubard Feinour & Brown's AGN Position: Q3 2019 in Review

Dixon Hubard Feinour & Brown sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 12,690 shares — an estimated $2.13M sold.

Dixon Hubard Feinour & Brown first reported a position in AGN in Q2 2013 and held it in 25 quarters. The position peaked at $5.11M in Q1 2015. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Dixon Hubard Feinour & Brown reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Dixon Hubard Feinour & Brown sold 12,690 Allergan plc shares in Q3 2019, an estimated $2.13M.
  • Dixon Hubard Feinour & Brown first reported a position in Allergan plc in Q2 2013 and held it in 25 quarters.
  • Dixon Hubard Feinour & Brown's Allergan plc position peaked at $5.11M in Q1 2015.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q3 2019, filed 13 Nov 2019.